Compare BHVN & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHVN | MNR |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2022 | 2023 |
| Metric | BHVN | MNR |
|---|---|---|
| Price | $14.38 | $13.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $29.08 | $18.00 |
| AVG Volume (30 Days) | ★ 2.9M | 247.8K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.29% |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,175,390,000.00 |
| Revenue This Year | N/A | $34.60 |
| Revenue Next Year | N/A | $2.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.22 |
| 52 Week Low | $7.48 | $10.46 |
| 52 Week High | $18.57 | $15.58 |
| Indicator | BHVN | MNR |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 60.92 |
| Support Level | $14.17 | $13.18 |
| Resistance Level | $17.01 | $13.87 |
| Average True Range (ATR) | 0.99 | 0.26 |
| MACD | -0.29 | 0.09 |
| Stochastic Oscillator | 20.49 | 77.39 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas; the San Juan Basin region of New Mexico and Colorado; and the Permian Basin region of West Texas. The company is organized and managed as a single reportable segment, which is the exploration and production of oil, natural gas and NGLs (E&P Segment).